Clinical and genetic analysis of a family diagnosed with familial hypobetalipoproteinemia in which the proband was diagnosed with diabetes mellitus

Atherosclerosis
Xiaoli WangZhongyan Shan

Abstract

To perform clinical and genetic analysis of a family with familial hypobetalipoproteinemia in which the proband had been diagnosed with diabetes mellitus. Direct sequencing was performed on candidate genes such as APOB, PCSK9, and ANGPTL3. The effect of the mutant gene on lipid profile was investigated using biochemical methods. A novel mutation Y344S in ANGPTL3 was identified but no variants were found in PCSK9 or APOB. Lipid profiles showed the levels of TG, TC, and LDL-C to be significantly lower in Y344S carriers than in non-carriers in this family. The levels of HDL-C and plasma concentrations of ANGPTL3 showed no significant differences. Western blot analysis revealed that the mutant ANGPTL3 proteins could not be secreted into the medium. A novel mutation Y344S was found in ANGPTL3 gene in two diabetic patients with familial hypobetalipoproteinemia. The family study and genetic analysis suggest that this set of gene mutation may be a genetic basis for the lipid phenotypes, and may become a vascular protective factor in the probands with high risk of atherosclerosis.

References

Jul 5, 2002·The Journal of Biological Chemistry·Tetsuya ShimizugawaHidehiko Furukawa
Apr 20, 2004·Biochemical and Biophysical Research Communications·Kouichi InukaiShigehiro Katayama
Apr 9, 2005·Cellular and Molecular Life Sciences : CMLS·G SchonfeldP Yue
Jul 23, 2008·Perspectives in Vascular Surgery and Endovascular Therapy·Kimon Bekelis, Nicos Labropoulos
Dec 17, 2008·The Journal of Clinical Investigation·Stefano RomeoJonathan C Cohen
Oct 24, 2009·Current Opinion in Lipidology·Takashi Miida, Satoshi Hirayama
Oct 15, 2010·The New England Journal of Medicine·Kiran MusunuruSekar Kathiresan
Nov 9, 2011·Circulation. Cardiovascular Genetics·Livia PisciottaStefano Bertolini
Dec 14, 2011·Clinica Chimica Acta; International Journal of Clinical Chemistry·Jesús M Martín-CamposFrancisco Blanco-Vaca
Jun 5, 2012·The Journal of Clinical Endocrinology and Metabolism·Ilenia MinicocciMarcello Arca

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.